EUVIMEDEUVIMED entdecken
Editorial

Regulatory news: Cipaglucosidase alfa‐atga (Pombiliti) coadministered with Miglustat (Opfolda) for adults with late‐onset Pompe disease

Daniela V Luquetti, Linda J B Jeng, Kathleen M Donohue, Janet W Maynard, Review Team

Journal of Inherited Metabolic Disease · 2024-07 · 47 (4) · 578-581

DOI: 10.1002/jimd.12744 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 20.05.2024. Verfasst von Daniela V Luquetti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of New Drugs, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, alpha-Glucosidases, 1-Deoxynojirimycin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type IIalpha-Glucosidases1-DeoxynojirimycinHumansAdultEnzyme Replacement TherapyDrug Therapy, CombinationDrug ApprovalAge of Onset

Substanzen

alpha-Glucosidases1-DeoxynojirimycinmiglustatGAA protein, human

Autor:innen und Institutionen

  • Office of New Drugs, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA.
  • Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Zitieren

APA

Luquetti, D. V., Jeng, L. J. B., Donohue, K. M., Maynard, J. W., & Review Team (2024). Regulatory news: Cipaglucosidase alfa‐atga (Pombiliti) coadministered with Miglustat (Opfolda) for adults with late‐onset Pompe disease. Journal of Inherited Metabolic Disease, 47(4), 578-581. https://doi.org/10.1002/jimd.12744

Vancouver

Luquetti DV, Jeng LJB, Donohue KM, Maynard JW, Review Team. Regulatory news: Cipaglucosidase alfa‐atga (Pombiliti) coadministered with Miglustat (Opfolda) for adults with late‐onset Pompe disease. Journal of Inherited Metabolic Disease. 2024;47(4):578-581. doi:10.1002/jimd.12744

BibTeX
@article{Luquetti2024,
  author = {Luquetti, Daniela V and Jeng, Linda J B and Donohue, Kathleen M and Maynard, Janet W and Review Team, Review Team},
  title = {Regulatory news: Cipaglucosidase alfa‐atga (Pombiliti) coadministered with Miglustat (Opfolda) for adults with late‐onset Pompe disease},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2024},
  volume = {47},
  number = {4},
  pages = {578--581},
  doi = {10.1002/jimd.12744}
}
Kostenlos starten →